furosemide has been researched along with Sarcopenia in 3 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
Sarcopenia: Progressive decline in muscle mass due to aging which results in decreased functional capacity of muscles.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The proportion of furosemide administration was higher in patients with cramping compared with those without." | 7.96 | Effect of furosemide on muscle cramps in patients with liver cirrhosis. ( Akahane, T; Fujinaga, Y; Furukawa, M; Kaji, K; Kawaratani, H; Kubo, T; Mitoro, A; Moriya, K; Namisaki, T; Saikawa, S; Sato, S; Sawada, Y; Shimozato, N; Takaya, H; Yoshiji, H, 2020) |
| "This study investigated time-course changes in skeletal muscle volume per year with tolvaptan in patients with refractory ascites that was unresponsive to loop diuretics and aldosterone antagonists." | 3.96 | Management of refractory ascites attenuates muscle mass reduction and improves survival in patients with decompensated cirrhosis. ( Aikata, H; Chayama, K; Fujino, H; Hiramatsu, A; Imamura, M; Kawaoka, T; Kodama, K; Morio, K; Murakami, E; Nakahara, T; Namba, M; Ohya, K; Tsuge, M; Uchikawa, S; Yamauchi, M, 2020) |
| "The proportion of furosemide administration was higher in patients with cramping compared with those without." | 3.96 | Effect of furosemide on muscle cramps in patients with liver cirrhosis. ( Akahane, T; Fujinaga, Y; Furukawa, M; Kaji, K; Kawaratani, H; Kubo, T; Mitoro, A; Moriya, K; Namisaki, T; Saikawa, S; Sato, S; Sawada, Y; Shimozato, N; Takaya, H; Yoshiji, H, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Namba, M | 1 |
| Hiramatsu, A | 1 |
| Aikata, H | 1 |
| Kodama, K | 1 |
| Uchikawa, S | 1 |
| Ohya, K | 1 |
| Morio, K | 1 |
| Fujino, H | 1 |
| Nakahara, T | 1 |
| Murakami, E | 1 |
| Yamauchi, M | 1 |
| Kawaoka, T | 1 |
| Tsuge, M | 1 |
| Imamura, M | 1 |
| Chayama, K | 1 |
| Mandai, S | 1 |
| Furukawa, S | 1 |
| Kodaka, M | 1 |
| Hata, Y | 1 |
| Mori, T | 1 |
| Nomura, N | 1 |
| Ando, F | 1 |
| Mori, Y | 1 |
| Takahashi, D | 1 |
| Yoshizaki, Y | 1 |
| Kasagi, Y | 1 |
| Arai, Y | 1 |
| Sasaki, E | 1 |
| Yoshida, S | 1 |
| Furuichi, Y | 1 |
| Fujii, NL | 1 |
| Sohara, E | 1 |
| Rai, T | 1 |
| Uchida, S | 1 |
| Sawada, Y | 1 |
| Kawaratani, H | 1 |
| Kubo, T | 1 |
| Fujinaga, Y | 1 |
| Furukawa, M | 1 |
| Saikawa, S | 1 |
| Sato, S | 1 |
| Takaya, H | 1 |
| Kaji, K | 1 |
| Shimozato, N | 1 |
| Moriya, K | 1 |
| Namisaki, T | 1 |
| Akahane, T | 1 |
| Mitoro, A | 1 |
| Yoshiji, H | 1 |
3 other studies available for furosemide and Sarcopenia
| Article | Year |
|---|---|
Management of refractory ascites attenuates muscle mass reduction and improves survival in patients with decompensated cirrhosis.
Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Ascites; Diuretics; Femal | 2020 |
Loop diuretics affect skeletal myoblast differentiation and exercise-induced muscle hypertrophy.
Topics: Animals; Bumetanide; Cell Differentiation; Cell Line; Disease Models, Animal; Diuretics; Furosemide; | 2017 |
Effect of furosemide on muscle cramps in patients with liver cirrhosis.
Topics: Aged; Diuretics; Female; Furosemide; Humans; Liver Cirrhosis; Male; Middle Aged; Muscle Cramp; Risk | 2020 |